Tapewire

Nasdaq · USD

AKBA

Akebia Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6105
SEC CIK
0001517022
Parsed reports
275

Last 12 months

Inside the activity.

1 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 2026015
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 02, 2021 Filed Jun 3, 2021 17:26 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-004027 · primarydocument.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,564

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $3.37 $0.00
Disclosure

SEC source: 0001562180-21-004030 · primarydocument.xml · derivative · entry 2

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2031-06-02

F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 21:27 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-004030 · primarydocument.xml · nonDerivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,533

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
April 01, 2021 Filed Apr 1, 2021 20:33 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 1,211 $3.40 $4,117.40
Disclosure

SEC source: 0001562180-21-002541 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,550

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
April 01, 2021 Filed Apr 2, 2021 00:35 UTC SaleCommon Stock 952 $3.40 $3,236.80
Disclosure

SEC source: 0001562180-21-002544 · primarydocument.xml · nonDerivative · entry 1

Faulkingham Dell · CIK 0001776024 · SVP, CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,025

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
April 01, 2021 Filed Apr 2, 2021 00:34 UTC
Spellman David ASVP, CFO and Treasurer
SaleCommon Stock 790 $3.40 $2,686.00
Disclosure

SEC source: 0001562180-21-002543 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,802

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
April 01, 2021 Filed Apr 2, 2021 00:33 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 1,060 $3.40 $3,604.00
Disclosure

SEC source: 0001562180-21-002542 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,303

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
April 01, 2021 Filed Apr 2, 2021 00:31 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 1,081 $3.40 $3,675.40
Disclosure

SEC source: 0001562180-21-002539 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,761

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
April 01, 2021 Filed Apr 2, 2021 00:32 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 4,109 $3.40 $13,970.60
Disclosure

SEC source: 0001562180-21-002540 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,152,153

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 19:17 UTC
Dahan MichelSVP, Chief Operating Officer
GrantCommon Stock 11,648 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-002355 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,761

F1 · shares: As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 23:19 UTC
Spellman David ASVP, CFO and Treasurer
GrantCommon Stock 7,592 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-002358 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,592

F1 · shares: As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 23:18 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantCommon Stock 10,192 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-002356 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,363

F1 · shares: As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 23:18 UTC GrantCommon Stock 9,152 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-002357 · primarydocument.xml · nonDerivative · entry 1

Faulkingham Dell · CIK 0001776024 · CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,977

F1 · shares: As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 23:17 UTC
Butler John P.Director · CEO and President
GrantCommon Stock 39,520 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-002354 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,156,262

F1 · shares: As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 23:16 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantCommon Stock 10,400 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-002353 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,842

F1 · shares: As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 16:08 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 7,945 $3.40 $26,982.01
Disclosure

SEC source: 0001562180-21-001784 · primarydocument.xml · nonDerivative · entry 3

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,113

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 16:08 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 6,602 $3.40 $22,421.05
Disclosure

SEC source: 0001562180-21-001784 · primarydocument.xml · nonDerivative · entry 2

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,058

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:10 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 24,674 $3.40 $83,795.37
Disclosure

SEC source: 0001562180-21-001787 · primarydocument.xml · nonDerivative · entry 3

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,116,742

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:10 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 25,316 $3.40 $85,975.67
Disclosure

SEC source: 0001562180-21-001787 · primarydocument.xml · nonDerivative · entry 2

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,141,416

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:08 UTC SaleCommon Stock 6,749 $3.40 $22,920.28
Disclosure

SEC source: 0001562180-21-001786 · primarydocument.xml · nonDerivative · entry 2

Faulkingham Dell · CIK 0001776024 · CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,825

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:08 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 7,976 $3.40 $27,087.29
Disclosure

SEC source: 0001562180-21-001785 · primarydocument.xml · nonDerivative · entry 3

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,171

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:08 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 6,309 $3.40 $21,425.99
Disclosure

SEC source: 0001562180-21-001785 · primarydocument.xml · nonDerivative · entry 2

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,147

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:06 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 7,558 $3.40 $25,667.72
Disclosure

SEC source: 0001562180-21-001781 · primarydocument.xml · nonDerivative · entry 2

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,442

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 16:08 UTC
Dahan MichelSVP, Chief Operating Officer
GrantEmployee Stock Option (Right to buy) · Derivative 110,000 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001562180-21-001784 · primarydocument.xml · derivative · entry 4

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2031-02-26

F5 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 16:08 UTC
Dahan MichelSVP, Chief Operating Officer
GrantCommon Stock 62,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001784 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,660

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2020 and 1,200 shares of the Issuer's common stock purchased on December 31, 2020, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:10 UTC
Butler John P.Director · CEO and President
GrantEmployee Stock Option (Right to buy) · Derivative 403,600 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001562180-21-001787 · primarydocument.xml · derivative · entry 10

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 403,600

Underlying: Common Stock · 403,600 shares

Expires 2031-02-26

F5 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:10 UTC
Butler John P.Director · CEO and President
GrantCommon Stock 237,400 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001787 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,166,732

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2020 and 1,200 shares of the Issuer's common stock purchased on December 31, 2020, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan, and transfer of shares of the Issuer's common stock which were contributed to two grantor retained annuity trusts.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:08 UTC GrantEmployee Stock Option (Right to buy) · Derivative 110,000 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001562180-21-001786 · primarydocument.xml · derivative · entry 3

Faulkingham Dell · CIK 0001776024 · CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2031-02-26

F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:08 UTC GrantCommon Stock 62,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001786 · primarydocument.xml · nonDerivative · entry 1

Faulkingham Dell · CIK 0001776024 · CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,574

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:08 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantEmployee Stock Option (Right to buy) · Derivative 110,000 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001562180-21-001785 · primarydocument.xml · derivative · entry 4

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2031-02-26

F5 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:08 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantCommon Stock 62,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001785 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,456

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2020 and 1,200 shares of the Issuer's common stock purchased on December 31, 2020, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:06 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantEmployee Stock Option (Right to buy) · Derivative 120,000 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001562180-21-001781 · primarydocument.xml · derivative · entry 3

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2031-02-26

F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:06 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantCommon Stock 70,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001781 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,000

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:06 UTC
Cotreau ViolettaSVP, Chief Accounting Officer
GrantEmployee Stock Option (Right to buy) · Derivative 44,200 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001562180-21-001774 · primarydocument.xml · derivative · entry 2

Cotreau Violetta · CIK 0001841934 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,200

Underlying: Common Stock · 44,200 shares

Expires 2031-02-26

F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:06 UTC
Cotreau ViolettaSVP, Chief Accounting Officer
GrantCommon Stock 26,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001774 · primarydocument.xml · nonDerivative · entry 1

Cotreau Violetta · CIK 0001841934 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,900

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:05 UTC
Spellman David ASVP, CFO and Treasurer
GrantEmployee Stock Option (Right to buy) · Derivative 120,000 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001562180-21-001767 · primarydocument.xml · derivative · entry 2

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2031-02-26

F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:05 UTC
Spellman David ASVP, CFO and Treasurer
GrantCommon Stock 70,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001767 · primarydocument.xml · nonDerivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 13:17 UTC GrantStock Option (Right to buy) · Derivative 80,200 $0.00 Strike: $4.87 $0.00
Disclosure

SEC source: 0001562180-21-001243 · primarydocument.xml · derivative · entry 1

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,200

Underlying: Common Stock · 80,200 shares

Expires 2031-02-16

F1 · derivative.exercise_date: The options will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:08 UTC
Spellman David ASVP, CFO and Treasurer
GrantEmployee Stock Option (Right to buy) · Derivative 280,000 $0.00 Strike: $13.58 $0.00
Disclosure

SEC source: 0000899243-20-018268 · doc4.xml · derivative · entry 1

Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,000

Underlying: Common Stock · 280,000 shares

Expires 2030-06-30

F1 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.

Read SEC document
June 08, 2020 Filed Jun 9, 2020 20:17 UTC
GOWEN MAXINEDirector
SaleCommon Stock 4,567 $12.05 $55,032.35
Disclosure

SEC source: 0001562180-20-004358 · primarydocument.xml · nonDerivative · entry 2

GOWEN MAXINE · CIK 0001280044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,133

F2 · kind: This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 6, 2019.

Read SEC document
June 08, 2020 Filed Jun 9, 2020 16:17 UTC SaleCommon Stock 4,567 $12.08 $55,169.36
Disclosure

SEC source: 0001562180-20-004359 · primarydocument.xml · nonDerivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,864

F2 · kind: This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 6, 2019.

Read SEC document
June 08, 2020 Filed Jun 9, 2020 20:17 UTC SaleCommon Stock 4,567 $12.10 $55,260.70
Disclosure

SEC source: 0001562180-20-004360 · primarydocument.xml · nonDerivative · entry 2

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,833

F2 · kind: This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 6, 2019.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:17 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001562180-20-004356 · primarydocument.xml · derivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2030-06-05

F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:17 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-004356 · primarydocument.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,886

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:17 UTC
GOWEN MAXINEDirector
GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001562180-20-004358 · primarydocument.xml · derivative · entry 3

GOWEN MAXINE · CIK 0001280044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2030-06-05

F3 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:17 UTC
GOWEN MAXINEDirector
GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-004358 · primarydocument.xml · nonDerivative · entry 1

GOWEN MAXINE · CIK 0001280044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,700

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:16 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001562180-20-004354 · primarydocument.xml · derivative · entry 2

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2030-06-05

F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:16 UTC
ADAMS ADRIANDirector
GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-004354 · primarydocument.xml · nonDerivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,400

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:17 UTC GrantStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001562180-20-004357 · primarydocument.xml · derivative · entry 2

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2030-06-05

F2 · shares: Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:17 UTC GrantCommon Stock 13,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-004357 · primarydocument.xml · nonDerivative · entry 1

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,629

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.